NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Great point rogers! It’s a keynote address that is a highlight of the conference.

Given what we know about Glioblastoma and the trials of the past, this is a big deal in the world of neuro-oncology. Everyone with an interest in glioblastoma will be tuned in.

Interesting thing about the talk:

Upon completion, participant will be able to assess whether patients with glioblastoma live longer if treated with dendritic cell-based immunization strategies.

Dr Liau is emphasizing survival. That’s a pretty bold point to highlight in glioblastoma. I’m not a mind reader, but I play one on the internet: I’d say she’s feeling good about the results.